Salesforce is undergoing a pivotal AI-driven transformation with Agentforce and is expected to accelerate revenue growth.

Increased fees for Salesforce’s Connector program are beginning to affect software vendors, potentially raising integration costs and complicating CIOs’ AI plans. CIOs may see price increases for ...

If you are wondering whether Salesforce is still worth buying after its big run over the last few years, you are not alone. This article aims to unpack what the current share price really implies ...

Salesforce (CRM) has been quietly grinding higher, with the stock up about 16% over the past month and roughly 8% in the past 3 months, even as its year-to-date return remains negative. See our latest ...

Salesforce Inc (NYSE: CRM) shares moved higher Wednesday after the company secured a major win with Novartis selecting its Agentforce Life Sciences platform for global customer engagement, while BTIG ...

The firm noted that Salesforce "remains committed to profitable growth" and described the current valuation as "very compelling at only 14x CY27E FCF." InvestingPro data shows management has been ...

Mizuho has reiterated an Outperform rating on Salesforce, maintaining a $340 price target, expressing confidence in the company’s improvements and growth positioning. Similarly, Cantor Fitzgerald has ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Morgan Stanley lowered the firm’s price target on Salesforce (CRM) to $398 from $405 and keeps an Overweight rating on the shares after adjusting estimates and valuations among the firm’s software ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...